EP 2285987 A2 20110223 - MODULATORS OF MCAM IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
Title (en)
MODULATORS OF MCAM IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
Title (de)
MCAM-MODULATOREN ZUR BEHANDLUNG VON AKNE, SEBORRHOISCHER DERMATITIS ODER HYPERSEBORRHOE
Title (fr)
MODULATEURS DE MCAM DANS LE TRAITEMENT DE L'ACNÉ, DE DERMATITE SÉBORRHÉIQUE OU D'HYPERSÉBORRHÉE
Publication
Application
Priority
- EP 2009055555 W 20090507
- US 7160208 P 20080507
- FR 0857706 A 20081113
Abstract (en)
[origin: WO2009135910A2] The invention relates to an in vitro or in vivo method for screening for candidate compounds for the preventive or curative treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea, comprising the determination of the ability of a compound to modulate the expression or the activity of the melanoma cell adhesion molecule (MCAM), and also to the use of modulators of the expression or of the activity of this protein, for the treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea. The invention also relates to methods for the in vitro diagnosis of or in vitro prognosis for these pathologies.
IPC 8 full level
C12Q 1/68 (2006.01); G01N 33/50 (2006.01)
CPC (source: EP)
C12Q 1/6883 (2013.01); G01N 33/6854 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/70503 (2013.01); G01N 2500/04 (2013.01); G01N 2800/20 (2013.01)
Citation (search report)
See references of WO 2009135910A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2009135910 A2 20091112; WO 2009135910 A3 20091223; EP 2285987 A2 20110223; FR 2938337 A1 20100514
DOCDB simple family (application)
EP 2009055555 W 20090507; EP 09742128 A 20090507; FR 0857706 A 20081113